Research Digest

Lab notes: Malaria drug might protect a foetus from the Zika virus

Hydroxychloroquine suppresses an immune mechanism in the placenta and also limits the growth of invading Zika viruses.

A commonly used malaria drug might protect foetuses from being infected with the Zika viruses, according to new research by scientists at the Washington University School of Medicine. This is an important finding with the possibly simple solution to prevent babies being born with developmental deformities associated with the disease.

India has just recorded its fourth case of Zika. A 27-year-old man in Tamil Nadu was found infected with the Zika virus. Three cases were detected earlier this year in Ahmedabad, Gujarat. Zika was declared a Public Health Emergency of International concern for much of 2016, after Zika infections were reported in many parts of the world and took a heavy toll on Brazil.

Zika often manifests as mild symptoms like fever and rash in adults but babies born to women infected with the virus can ave microcephaly, a condition in which the brain is small and underdeveloped. So far, there has been no vaccine or drug to protect pregnant women and their foetuses from infection.

A team of scientists from Washington University School of Medicine have studied pregnant mice infected with Zika and found that the Zika virus infects a foetus by manipulating the body’s normal barrier to infection. The body normally mobilises many defensive mechanisms to protect a growing foetus and the placenta is the last line of defense against infection being transmitted from the mother. The research team had previously found that the Zika virus can invade rhe placenta and also multiply there.

To learn more about how Zika breaches the placenta, the researchers infected human placental cells with Zika virus and that the virus then activated genes related to autophagy – the process by which cells disposed waste and invading microbes. When they treated the cells with drugs to ramp up the autophagy pathway, they found that a larger number of cells became infected with the Zika virus increased. Drugs that suppressed autophagy resulted in fewer placental cells infected with Zika virus. This showed that the virus was able to manipulate the body’s own defenses against it.

Human placental cells (blue) infected with Zika virus (green) responded to the malaria drug chloroquine (left). (Photo: Bin Cao/Washington University School of Medicine)
Human placental cells (blue) infected with Zika virus (green) responded to the malaria drug chloroquine (left). (Photo: Bin Cao/Washington University School of Medicine)

They then tested the malaria drug hydroxychloroquine – a drug known to suppress autophagy – on pregnant mice. They found significantly lower levels of the virus in foetuses and placentas of mice that had received hydroxychloroquine in comparison to pregnant mice that had been given a placebo. In addition, these placentas of mice that received the malaria drug also showed less damage and the foetuses regained normal growth. Both the untreated and the treated mice mothers had about the same amount of Zika virus in their bloodstreams. The results published in The Journal of Experimental Medicine indicate that hydroxychloroquine was able to protect foetuses even when the virus was circulating through the mother.

The drug is already is approved for use in pregnant women for other medical purposes and the research team suggests further evaluation of the drug in primates and women for use to lower the risks of Zika infection.

Support our journalism by subscribing to Scroll+ here. We welcome your comments at letters@scroll.in.
Sponsored Content BY 

The qualities of a high-performance luxury sedan

A lesson in harnessing tremendous power to deliver high performance.

Gone are the days when the rich and successful would network during a round of golf, at least in the Silicon Valley. As reported by New York Times, ‘auto-racing has become a favourite hobby for the tech elites’. However, getting together on a race track would require a machine that provides control while testing extreme limits. Enter the Mercedes-AMG range of cars.

Mercedes-AMG’s rise from a racing outfit to a manufacturer of peak performance cars is dotted with innovations that have pushed the boundaries of engineering. While the AMG series promises a smooth driving experience, its core is made up of a passion for motorsports and a spirit that can be summarized in two words – power and performance. These integral traits draw like-minded people who share and express Mercedes-AMG’s style of performance.

The cars we drive say a lot about us, it’s been said. There are several qualities of an AMG performance luxury sedan that overlap with the qualities of its distinguished owner. For instance, creating an impression comes naturally to both, so does the ambition to always deliver an exceptional performance. However, the strongest feature is that both the owner and the AMG marque continually challenge themselves in pursuit of new goals, stretching the limits of performance.

This winning quality comes alive, especially, in the latest Mercedes-AMG marque – the Mercedes-AMG E 63 S 4MATIC+. With the most powerful engine to have ever been installed in an E-class, this undisputed performance sedan promises immense power at the driver’s command. With 612 HP under its hood, the car achieves 0-100 km/h in just a few seconds - 3.4 to be precise. Moreover, the car comes with the latest driver-assistance technology that promises intelligent control and provides an agile and responsive ride.

But, the new AMG is not just about work (or traction in car lingo). One of its core features is to provide its owners a challenge on the race track. Its drift mode, which converts the vehicle into a pure rear-wheel drive, offers pure exhilaration and adds a work-play dynamic to the car. In that sense, the new AMG is a collaborator of sorts - one that partners with its owner to create an impression through performance. And on the weekends, the car pushes him/her to express absolute power using its race mode with a thunderous roar of the engine - the pure sound of adrenalin. This balance between work and play has been achieved using cutting-edge features in the car that together create an almost intuitive driver-machine relationship.

If you’re looking for a car that shares your enthusiasm for driving, you’ll find a partner in the new AMG. However, buying an AMG is not just about owning a powerhouse on wheels, it’s also about adopting a driving philosophy in which power is just the starting point - the main skill lies in how you manoeuvre that power on the road. A performance sedan in its sportiest form, Mercedes-AMG’s latest model takes vehicle performance to an unmatched level. A decade ago, this amount of speed and power in a luxury 4-door model would be un-thinkable.

Play

The new Mercedes-AMG comes with a host of individualisation options through designo, the artistic side of Mercedes’s innovation, so the car becomes an extension of the owner’s distinctive personality. An expressive design with a new radiator grille and a muscular front apron showcase its athleticism. A new-age driver environment, widescreen cockpit, the AMG performance steering wheel and sports seat delivers an intensive driving experience. With the Mercedes-AMG E 63 S 4MATIC+, AMG has created an undisputed performance sedan that can rip the race track as well as provide reliable luxury sedan-duty. To know more about the most powerful E-class of all time, see here.

This article was produced by the Scroll marketing team on behalf of Mercedes-Benz and not by the Scroll editorial team.